Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Van Dreden, Patrick; Fareed, Jawed; Elalamy, Ismail; Gerotziafas, Grigoris

Van Dreden, Patrick; Fareed, Jawed; Elalamy, Ismail; Gerotziafas, Grigoris.

Van Dreden P; Sorbonne Université, INSERM, UMR_S 938, Research Group « Cancer, Biology and Therapeutics ¼, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Fareed J; Clinical Research Department, Diagnostica Stago, Gennevilliers, France.
Elalamy I; Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
Gerotziafas G; Department of Pharmacology and Neuroscience, Cardiovascular Research Institute, Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.

Clin Appl Thromb Hemost ; 27: 10760296211033906, 2021.

Article in English | MEDLINE | ID: covidwho-1484250

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Immunogenicity, Vaccine; Vaccination; BNT162 Vaccine; COVID-19/immunology; COVID-19/virology; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/immunology; ChAdOx1 nCoV-19; Clinical Trials as Topic; Humans; Immunization Schedule; Research Design; Time Factors; Treatment Outcome

Keywords

COVID-19; mRNA; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Immunogenicity, Vaccine / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 10760296211033906

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google